OSR Holdings, Inc. (OSRH, OSRHW)

OSR Holdings (OSRH) is a post‑SPAC healthcare holding company with three primary subsidiaries: Vaximm (oral cancer immunotherapies in phase 1/2 clinical trials with orphan designations), Darnatein (design‑augmented biologics for bone/cartilage regeneration, early clinical data for spinal fusion a...